Implantable superelastic anastomosis device

Information

  • Patent Grant
  • 7303569
  • Patent Number
    7,303,569
  • Date Filed
    Friday, June 13, 2003
    21 years ago
  • Date Issued
    Tuesday, December 4, 2007
    17 years ago
Abstract
A one piece anastomosis device is disclosed which is formed of a superelastic or pseudoelastic material which self deforms or self deploys from an insertion configuration to a tissue holding configuration. The device in a deployed state preferably includes an inner tissue penetrating flange which penetrate and retains an everted graft vessel and an outer flange. The self deploying anastomosis device does not rely on a temperature transformation to achieve deployment.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The invention relates to an implantable medical device such as an anastomosis device and a deployment system for implanting the device. In a preferred embodiment, the device can be used for forming a sutureless connection between a bypass graft and a blood vessel.


2. Brief Description of the Related Art


Vascular anastomosis is a procedure by which two blood vessels within a patient are surgically joined together. Vascular anastomosis is performed during treatment of a variety of conditions including coronary artery disease, diseases of the great and peripheral vessels, organ transplantation, and trauma. In coronary artery disease (CAD) an occlusion or stenosis in a coronary artery interferes with blood flow to the heart muscle. Treatment of CAD involves the grafting of a vessel in the form of a prosthesis or harvested artery or vein to reroute blood flow around the occlusion and restore adequate blood flow to the heart muscle. This treatment is known as coronary artery bypass grafting (CABG).


In the conventional CABG, a large incision is made in the chest and the sternum is sawed in half to allow access to the heart. In addition, a heart lung machine is used to circulate the patient's blood so that the heart can be stopped and the anastomosis can be performed. During this procedure, the aorta is clamped which can lead to trauma of the aortic tissue and/or dislodge plaque emboli, both of which increase the likelihood of neurological complications. In order to minimize the trauma to the patient induced by conventional CABG, less invasive techniques have been developed in which the surgery is performed through small incisions in the patients chest with the aid of visualizing scopes. Less invasive CABG can be performed on a beating or stopped heart and thus may avoid the need for cardiopulmonary bypass.


In both conventional and less invasive CABG procedures, the surgeon has to suture one end of the graft vessel to the coronary artery and the other end of the graft vessel to a blood supplying vein or artery. The suturing process is a time consuming and difficult procedure requiring a high level of surgical skill. In order to perform the suturing of the graft to the coronary artery and the blood supplying artery the surgeon must have relatively unobstructed access to the anastomosis site within the patient. In the less invasive surgical approaches, some of the major coronary arteries including the ascending aorta cannot be easily reached by the surgeon because of their location. This makes suturing either difficult or impossible for some coronary artery sites. In addition, some target vessels, such as heavily calcified coronary vessels, vessels having very small diameter, and previously bypassed vessels may make the suturing process difficult or impossible.


Accordingly, it would be desirable to provide a sutureless vascular anastomosis device which easily connects a graft to a target vessel. It would also be desirable to provide a sutureless anastomosis device which is formed of one piece and is secured to the target vessel in a single step.


SUMMARY OF THE INVENTION

A superelastic or pseudoelastic one piece anastomosis device according to the present invention connects a graft vessel to a target vessel. The anastomosis device deforms from an insertion configuration to a tissue holding configuration due to the superelastic or pseudoelastic properties of the material.


In accordance with one aspect of the present invention, a one piece anastomosis device for connecting a graft vessel to a target vessel includes a device body formed of a superelastic or pseudoelastic material. The device body has an insertion configuration and a tissue holding configuration in which the body has an inner flange and an outer flange. At least one of the inner and outer flanges is radially constrained in the insertion configuration for insertion into the target vessel. When the device body is released it self deforms to the tissue holding configuration.


In accordance with another aspect of the present invention, a tube deployed anastomosis system for connecting a graft vessel to a target vessel includes a deployment tube and an anastomosis device formed of a superelastic or pseudoelastic material. The device has an insertion configuration and a tissue holding configuration in which the device has an inner flange and an outer flange. The inner and outer flanges are radially constrained in the deployment tube in the insertion configuration for insertion into the target vessel and when released from the deployment tube, the device self deforms to the tissue holding configuration.


In accordance with another further aspect of the present invention, a method of deploying an anastomosis system for connecting a graft vessel to a target vessel includes the steps of: connecting a graft vessel to a one piece device formed of a superelastic or pseudoelastic material; poking a portion of the one piece device through the graft vessel; and deploying the one piece device by self deformation to a tissue holding configuration in which the device has an inner flange and an outer flange and traps the target vessel tissue between the inner flange and the outer flange.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention will now be described in greater detail with reference to the preferred embodiments illustrated in the accompanying drawings, in which like elements bear like reference numerals, and wherein:



FIG. 1 is a perspective view of a first embodiment of an anastomosis device in a constrained configuration prior to use;



FIG. 2 is a perspective view of the anastomosis device of FIG. 1 in a deployed configuration;



FIG. 3 is a side cross sectional view of the anastomosis device of FIG. 1 with a graft vessel everted around the device and the device constrained by a tube prior to deployment;



FIG. 4 a side cross sectional view of the system of FIG. 3 being inserted into a target vessel:



FIG. 5 is a side cross sectional view of the system of FIG. 3 after release of an inner flange;



FIG. 6 is a side cross sectional view of the system of FIG. 3 with the inner flange imbedded in an inner wall of the target vessel wall;



FIG. 7 is a side cross sectional view of the system of FIG. 3 after release of the outer flange showing the deployment tube being removed;



FIG. 8 is a perspective view of an alternative embodiment of an anastomosis device in a constrained configuration prior to use;



FIG. 9 is a perspective view of the anastomosis device of FIG. 8 in a deployed configuration;



FIG. 10 is side cross sectional view of the anastomosis device of FIG. 8 after deployment shown connecting a graft and a target vessel;



FIG. 11 is a perspective view of an alternative embodiment of an anastomosis device in a constrained configuration prior to use;



FIG. 12 is a perspective view of the anastomosis device of FIG. 11 in a deployed configuration;



FIG. 13 is a side cross sectional view of the anastomosis device of FIG. 11 after deployment shown connecting a graft vessel to a target vessel;



FIG. 14 is a perspective view of an alternative embodiment of an anastomosis device in a constrained configuration prior to use;



FIG. 15 is a perspective view of the anastomosis device of FIG. 14 in a deployed configuration;



FIG. 16 is a perspective view of an alternative embodiment of an expandable body anastomosis device in a constrained configuration prior to use; and



FIG. 17 is a perspective view of the anastomosis device of FIG. 16 in a deployed configuration.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

The present invention relates to a superelastic or pseudoelastic anastomosis device and method for connecting a graft vessel to a target vessel without the use of conventional sutures. The quick and easy deployment of the anastomosis system according to the present invention greatly increases the speed with which anastomosis can be performed over the known sutured anastomosis methods. The anastomosis devices according to the present invention are particularly designed for use in connecting graft vessels to target vessel in a variety of anastomosis procedures, including coronary artery bypass grafting. In such procedures, a large vessel anastomotic device is used to connect a graft vessel to large diameter target vessels such as the aorta or it's major side branches and a small vessel anastomotic device is used for connecting a graft vessel to a target vessel having a small diameter such as a coronary artery.


Suturing a graft vessel to a target vessel with conventional procedures is difficult and time consuming, particularly in minimally invasive procedures where space may be limited and in procedures in which it may be desired to perform an anastomosis without stoppage of blood flow through the target vessel. The superelastic or pseudoelastic anastomosis device and method of the present invention allow anastomosis to be performed efficiently and effectively in tight spaces. The anastomosis may also be performed with or without stoppage of blood flow in a target vessel and with or without the use of cardiopulmonary bypass.



FIG. 1 illustrates an anastomosis device 10 according to a first embodiment of the present invention in a constrained insertion configuration in which the anastomosis device would be inserted into a target blood vessel. FIG. 2 illustrates the anastomosis device 10 of FIG. 1 in an expanded deployed configuration which holds a graft vessel to a target vessel. The superelastic or the pseudoelastic anastomosis device in FIG. 1 includes a substantially cylindrical body 14, a plurality of legs 16 extending from a first side of the body, and a plurality of hooks 18 extended from a second side of the body. In the insertion configuration illustrated in FIG. 1, the body 14, the legs 16, and the hooks 18, are substantially aligned in a constrained substantially cylindrical shape. The anastomosis device 10 may be held in the constrained substantially cylindrical shape by a deployment tool, such as a substantially cylindrical deployment tube. When the deployment tool is removed from the device 10, the device returns to a preset expanded shape illustrated in FIG. 2 due to the superelastic or pseudoelastic properties of the material.


The anastomosis device 10 is made of a pseudoelastic or superelastic alloy, such as Nitenol or other pseudoelastic or superelastic material. The superelastic or pseudoelastic device 10 will self deform through superelastic or pseudoelastic behavior from the constrained insertion configuration illustrated in FIG. 1 to the expanded configuration illustrated in FIG. 2 when the constraining device or deployment tool is removed. The anastomosis device 10 formed of the superelastic or pseudoelastic material is formed in the final shape illustrated in FIG. 2 and is then isothermally deformed by constraining in a tube or other deployment tool in the substantially cylindrical shape illustrated in FIG. 1. The need for temperature control is avoided since the anastomosis device 10 reforms the deployed shape of FIG. 2 spontaneously when removed from the constraining tube. This allows the accurate placement of the anastomosis device 10 spontaneous and nearly instantaneously upon deployment of the device. The need for a mechanical deployment device to mechanically deform the anastomosis device from the insertion configuration to the deployed configuration is also avoided.


The anastomosis devices of the present invention may be made of any known superelastic or pseudoelastic material. U.S. Pat. No. 5,597,378 provides a discussion of superelastic and pseudoelastic materials and is incorporated herein by reference in its entirety.


The deployed anastomosis device 10 as shown in FIG. 2 includes an inner flange formed by outwardly extruding ends 22 of the J-shaped hooks 18. The deployed device 10 also includes an outer flange formed by the legs 16 extending outward from the body 14.


In use, a graft vessel 30, shown in FIG. 3, is threaded through a center of the anastomosis device 10. An end 34 of the graft vessel 30 is everted around the hooks 18 and the hook ends 22 penetrate into or through the everted end 34 of the graft vessel retaining the graft vessel in place on the anastomosis device 10.


As illustrated in FIG. 3, the anastomosis device 10 with the everted graft vessel 30 is positioned within a deployment tube 38 for delivery of the anastomosis device and graft vessel to an opening 40 in a target vessel 32. In the radially constrained insertion configuration, the leading edge or hook end of the anastomosis device may be substantially cylindrical or slightly conical for ease of insertion.


One embodiment of a method for deploying the anastomosis device 10 of the present invention will be described with reference to FIGS. 3-6. As shown in FIG. 3, the graft vessel 30 is prepared by everting an end 34 of the graft vessel around the hooks 18 of the anastomosis device 10. The hook ends 22 penetrate the graft vessel tissue to maintain the everted configuration of the graft vessel. The hooks 18 and the legs 16 of the anastomosis device 10 are radially constrained by inserting the anastomosis device 10 and everted end of the graft vessel 30 into a deployment tool 38 in the shape of a tube. When positioned inside the deployment tool 38, the anastomosis device 10 is in a generally cylindrical configuration for insertion into the target vessel 32.


As shown in FIG. 4, the deployment tool 38 is used to insert the anastomosis device 10 and the graft vessel 30 into the target vessel 32 until the hook ends 22 have passed through the opening 40 and are positioned within an interior of the blood vessel. As shown in FIGS. 3 and 4, a retainer tube 36 is positioned around the graft vessel 30 and inside the deployment tool 38 for holding and extruding the anastomosis device 10. A distal end 48 of the retainer tube 46 is positioned adjacent to a proximal end of the anastomosis device 10. The distal end 48 of the retainer tube 46 may be attached to or abut the anastomosis device 10 to hold the anastomosis device in place inside the deployment tube 38 during the insertion step of FIG. 4.


As shown in FIG. 5, the anastomosis device 10 is held in place by the retainer tube 46 while the deployment tube 38 is withdrawn or retracted to release the radial constraining force from the hooks 18. Upon removal of the deployment tube 38 from the hooks 18, the hook ends 22 and hook base portion 24 spontaneously spring outward due to the superelasticity or pseudoelasticity of the material.


As shown in FIG. 6, after the release of the hooks 18 the anastomosis device 10 is withdrawn by the deployment tool 38 against the interior wall of the target vessel 32 causing the hook ends 22 to be compressed against or penetrate into the tissue of the interior wall of the target vessel. The deployment tube 38 is then completely withdrawn as shown in FIG. 7 allowing the legs 16 to spontaneously spring outward to trap the wall of the target vessel 32 between the hooks 18 which form an inner flange and the legs 16 which form an outer flange for the deployed anastomosis device 10.



FIGS. 8-10 illustrate an alternative embodiment of an anastomosis device 50 having a central body portion 54. A first set of legs 56 extend from one end of the body 54 and a second set of pointed legs 58 extend from the second side of the body. In a constrained configuration illustrated in FIG. 8, the anastomosis device 50 is substantially tubular for insertion into a target vessel. In an expanded deployed configuration, illustrated in FIGS. 9 and 10, the anastomosis device 50 is substantially C-shaped in cross section with the legs 56 forming an outer flange and the pointed legs 58 forming an inner flange of the anastomosis device 50.


The embodiment shown in FIGS. 8-10 may be deployed in a manner similar to that of the anastomosis device described above with respect to FIGS. 1-7. As shown in FIG. 10, the graft vessel 62 is everted around the anastomosis device 50. The anastomosis device 50 and graft vessel 62 are then inserted into an opening in the target vessel 64 in a constrained configuration. A constraining device such as the deployment tool 38 is then removed from the anastomosis device 50 and graft vessel 62 allowing the legs 56 and 58 to spontaneously spring outward by the superelastic or pseudoelastic properties of the material to form inner and outer flanges which trap the tissue of the target vessel 64 between the inner and outer flanges.


According to one preferred embodiment of the anastomosis device 50 the pointed legs 58 each include a pointed tissue penetrating end 66 and a rectangular stop member 68 for limiting the tissue penetration of the penetrating end. As shown in FIG. 10, the tissue penetrating end 66 of the pointed legs 58 penetrates into or through the graft vessel 62 to ensure the graft vessel is retained on the anastomosis device 50 during and after deployment.


In the deployed configuration illustrated in FIG. 10, the intima of the graft vessel 62 abuts an intima of the target vessel 64. Thus, the expansion of the inner flange of the anastomosis device 50 forms a vein gasket to seal the graft and target vessels together.



FIGS. 11-13 illustrate an alternative embodiment of the superelastic or pseudoelastic anastomosis device 80 in a radially constrained configuration illustrated in FIG. 11 and in an expanded tissue retaining configuration illustrated in FIGS. 12 and 13. The anastomosis device 80 includes a device body 84 formed of a plurality of substantially parallel spring elements 86 interconnecting to end members 88. Extending from the end members 88 are a plurality of prongs 90 which in the expanded tissue supporting configuration illustrated in FIG. 13, form inner and outer flanges to trap the tissue of the target vessel 96. As in the previous embodiments, a graft vessel 94 is inserted through a center of the anastomosis device body 84 and is everted around the prongs 90 of at least one end the device body. The prongs 90 penetrate into or through the graft vessel tissue to retain the graft vessel on the anastomosis device.


The anastomosis device 80 with the graft vessel 94 everted around the anastomosis device is inserted in a radially constrained configuration illustrated in FIG. 11 into an opening in the target vessel 96. When the radially constraining member such as a retainer tube is removed from the anastomosis device 80, the anastomosis device spontaneously self deforms and returns to the configuration of FIG. 12 due to the superelastic or pseudoelastic properties of the material.


As shown in FIG. 13, a first set of the prongs 90 forms a flange at the inner wall of the target vessel. The spring elements 86 allow the distance between the end members 88 to adjust somewhat to target vessels 96 having walls of different thicknesses. The spring elements 86 may also apply a compression force to the wall of the target vessel 96 once the anastomosis device 80 has been deployed to provide improved sealing.


In an alternate embodiment of the anastomosis device 80 of FIGS. 11-13, the graft vessel 94 may be attached to the anastomosis device without everting. This may be done by providing axial prongs, hooks, or barbs on the inner rail member 88 and hooking an end of the graft vessel on the hooks, prongs, or barbs without everting.


An alternative embodiment of an anastomosis device 100 includes an anastomosis device body 104, legs 106, and hooks 108, as in the embodiment of FIGS. 1 and 2. The embodiment of FIGS. 14 and 15 differs from the embodiment of FIGS. 1 and 2 in that the legs 106 are folded outward and downward adjacent the body 104 in the radially constrained insertion configuration illustrated in FIG. 14. The legs 106 will spontaneously spring out to the flange forming configuration of FIG. 15 when the radially constraining member such as a retainer tube is removed for deployment of the anastomosis device 100.



FIGS. 16 and 17 illustrate an alternative embodiment of an anastomosis device 200 including a device body 204, legs 206 and pointed legs 208. The body 204 is formed of axially extending members 210 interconnected by struts 212 which allow the body to expand radially. Positioned between the body 204 and the pointed legs 208 are hinges 214. FIG. 16 illustrates the anastomosis device 200 in a radially constrained insertion configuration with a graft vessel 220 extending through an interior of the device body 204 and everted over the pointed legs 208. The pointed legs 208 penetrate and hold the everted end of the graft vessel 220 on the device 200.


For insertion, the anastomosis device 200 of FIG. 16 is radially constrained in a deployment tube (not shown). As the deployment tube is withdrawn from the device 200, the pointed legs 208 fold outward to form an inner flange, the device body 204 expands radially, and the legs 206 fold outward to form an outer flange. The radially expanding body 204 helps to stretch and support an opening in the target vessel.


Each of the anastomosis devices according to the present invention are preferably single piece devices which are formed in a substantially tubular shape. The anastomosis devices may be formed by laser cutting or punching from a tube or sheet of superelastic or pseudoelastic material. Alternatively, the devices may be formed from superelastic or pseudoelastic wire. The devices may be provided in varying sizes to join vessels of different sizes. The legs, hooks, prongs, and other device elements which have been discussed above with regard to the various embodiments may be used in varying numbers and arrangements depending on the particular application.


The invention has been described as an anastomosis device which is constrained for insertion in a radially constrained configuration with a deployment tool such as tube. However, the deployment tube may take other non-tubular shapes.


Although the invention has been primarily discussed with respect to coronary artery bypass surgery, the anastomosis devices of the present invention may by used in other types of anastomosis procedures. For example, the anastomosis device may be used in femoral-femoral bypass, vascular shunts, subclavian-carotid bypass, organ transplants, and the like. The devices according to the present invention may be used with venous grafts such as a harvested saphenous vein graft, arterial graft, such as a dissected mammal artery, or a synthetic prosthesis, as required.


Finally, the anastomosis devices according to the present invention have been illustrated as substantially cylindrical members. However, the devices can also be shaped into ovals, football shapes, or other shapes. Oval shapes can be particularly useful for accommodating small target vessels.


While the invention has been described in detail with reference to the preferred embodiments thereof, it will be apparent to one skilled in the art that various changes and modifications can be made and equivalents employed, without departing from the present invention.

Claims
  • 1. A system for performing anastomosis between a graft vessel and a target vessel, comprising: an anastomosis device, comprising a body having at least one flange, wherein said body is composed at least partially of superelastic material, and wherein said body has a lumen therethrough; anda deployment tool configured to deploy said anastomosis device, comprising a deployment tube, anda retainer tube slidable relative to and positioned within said deployment tube,wherein the distal end of said retainer tube is configured to engage said anastomosis device; wherein the distal end of said retainer tube is detachably connected to said anastomosis device;wherein at least part of said anastomosis device is positioned between said deployment tube and said retainer tube at a location at which a line radially extending from and perpendicular to the longitudinal centerline of said deployment tube intersects said deployment tube, said retainer tube and said anastomosis device.
  • 2. The system of claim 1, wherein the distal end of said retainer tube abuts the proximal end of said anastomosis device.
  • 3. The system of claim 1, wherein relative motion of said retainer tube and said deployment tube allows said anastomosis device to self-deform from an constrained configuration to a deployed configuration.
  • 4. The system of claim 1, wherein said deployment tube and said retainer tube are substantially concentric.
  • 5. The system of claim 1, wherein said body is substantially tubular.
  • 6. The system of claim 1, wherein said superelastic material is nickel-titanium alloy.
  • 7. The system of claim 1, wherein said body, said inner flange members and said outer flange members are self-deformable from an constrained configuration to a deployed configuration.
  • 8. The system of claim 7, wherein at least part of each said inner flange member is further from a longitudinal axis of said body in said deployed configuration than in said undeployed configuration.
  • 9. The system of claim 1, wherein said body has a first end and a second end, and wherein said outer flange members are spaced substantially evenly along the perimeter of said first end.
  • 10. The system of claim 1, wherein said body has a first end and a second end, and wherein said inner flange members are spaced substantially evenly along the perimeter of said second end.
US Referenced Citations (193)
Number Name Date Kind
3155095 Brown Nov 1964 A
3254650 Collito Jun 1966 A
3519187 Kapitanov et al. Jul 1970 A
3591102 Keiner Jul 1971 A
3774615 Lim et al. Nov 1973 A
4214587 Sakura, Jr. Jul 1980 A
4350160 Kolesov et al. Sep 1982 A
4352358 Angelchik Oct 1982 A
4366819 Kaster Jan 1983 A
4368736 Kaster Jan 1983 A
4503568 Madras Mar 1985 A
4523592 Daniel Jun 1985 A
4553542 Schenck et al. Nov 1985 A
4589416 Green May 1986 A
4593693 Schenck Jun 1986 A
4603693 Conta et al. Aug 1986 A
4607637 Berggren et al. Aug 1986 A
4624255 Schenck et al. Nov 1986 A
4624257 Berggren et al. Nov 1986 A
4657019 Walsh Apr 1987 A
4665906 Jervis May 1987 A
4747407 Liu et al. May 1988 A
4752024 Green et al. Jun 1988 A
4883453 Berry et al. Nov 1989 A
4892098 Sauer Jan 1990 A
4907591 Vasconcellos et al. Mar 1990 A
4917087 Walsh et al. Apr 1990 A
4917090 Berggren et al. Apr 1990 A
4917091 Berggren et al. Apr 1990 A
4930674 Barak Jun 1990 A
5005749 Aranyi Apr 1991 A
5062842 Tiffany Nov 1991 A
5104025 Main et al. Apr 1992 A
5119983 Green et al. Jun 1992 A
5129913 Ruppert Jul 1992 A
5156613 Sawyer Oct 1992 A
5171262 MacGregor Dec 1992 A
5187796 Wang et al. Feb 1993 A
5193731 Aranyi Mar 1993 A
5205459 Brinkerhoff et al. Apr 1993 A
5217474 Zacca et al. Jun 1993 A
5221281 Klicek Jun 1993 A
5222963 Brinkerhoff et al. Jun 1993 A
5234447 Kaster et al. Aug 1993 A
5250058 Miller et al. Oct 1993 A
5250060 Carbo et al. Oct 1993 A
5271544 Fox et al. Dec 1993 A
5275322 Brinkerhoff et al. Jan 1994 A
5285945 Brinkerhoff et al. Feb 1994 A
5290298 Rebuffat et al. Mar 1994 A
5292053 Bilotti et al. Mar 1994 A
5304220 Maginot Apr 1994 A
5314435 Green et al. May 1994 A
5314468 Ramos Martinez May 1994 A
5333773 Main et al. Aug 1994 A
5336233 Chen Aug 1994 A
5350104 Main et al. Sep 1994 A
5354302 Ko Oct 1994 A
5364389 Anderson Nov 1994 A
5366462 Kaster et al. Nov 1994 A
5392979 Green et al. Feb 1995 A
5395030 Kuramoto et al. Mar 1995 A
5395311 Andrews Mar 1995 A
5443497 Venbrux Aug 1995 A
5447514 Gerry et al. Sep 1995 A
5454825 Van Leeuwen Oct 1995 A
5456712 Maginot Oct 1995 A
5456714 Owen Oct 1995 A
5464449 Ryan et al. Nov 1995 A
5465895 Knodel et al. Nov 1995 A
5478354 Tovey et al. Dec 1995 A
5503635 Sauer et al. Apr 1996 A
5515478 Wang May 1996 A
5522834 Fonger et al. Jun 1996 A
5524180 Wang et al. Jun 1996 A
5533661 Main et al. Jul 1996 A
5540677 Sinofsky Jul 1996 A
5553198 Wang et al. Sep 1996 A
5556405 Lary Sep 1996 A
5558667 Yarborough et al. Sep 1996 A
5571167 Maginot Nov 1996 A
5643340 Nunokawa Jul 1997 A
5645520 Nakamura et al. Jul 1997 A
5657429 Wang et al. Aug 1997 A
5669918 Balazs et al. Sep 1997 A
5669934 Sawyer Sep 1997 A
5676670 Kim Oct 1997 A
5693088 Lazarus Dec 1997 A
5695504 Gifford, III et al. Dec 1997 A
5702412 Popov et al. Dec 1997 A
5707362 Yoon Jan 1998 A
5707380 Hinchliffe et al. Jan 1998 A
5709335 Heck Jan 1998 A
5709693 Taylor Jan 1998 A
5725544 Rygaard Mar 1998 A
5725553 Moenning Mar 1998 A
5732872 Bolduc et al. Mar 1998 A
5754741 Wang et al. May 1998 A
5762458 Wang et al. Jun 1998 A
5779718 Green et al. Jul 1998 A
5792135 Madhani et al. Aug 1998 A
5797900 Madhani et al. Aug 1998 A
5797920 Kim Aug 1998 A
5799661 Boyd et al. Sep 1998 A
5799857 Robertson et al. Sep 1998 A
5807377 Madhani et al. Sep 1998 A
5814073 Bonutti Sep 1998 A
5815640 Wang et al. Sep 1998 A
5817113 Gifford, III et al. Oct 1998 A
5827316 Young et al. Oct 1998 A
5833698 Hinchliffe et al. Nov 1998 A
5841950 Wang et al. Nov 1998 A
5855583 Wang et al. Jan 1999 A
5868763 Spence et al. Feb 1999 A
5875782 Ferrari et al. Mar 1999 A
5878193 Wang et al. Mar 1999 A
5879371 Gardiner et al. Mar 1999 A
5881943 Heck et al. Mar 1999 A
5893369 Lemole Apr 1999 A
5904697 Gifford, III et al. May 1999 A
5907664 Wang et al. May 1999 A
5911036 Wright et al. Jun 1999 A
5915616 Viola et al. Jun 1999 A
5921995 Kleshinski Jul 1999 A
5944730 Nobles et al. Aug 1999 A
5947363 Bolduc et al. Sep 1999 A
5957363 Heck Sep 1999 A
5976159 Bolduc et al. Nov 1999 A
6001124 Bachinski Dec 1999 A
6007544 Kim Dec 1999 A
6013190 Berg Jan 2000 A
6015416 Stefanchik et al. Jan 2000 A
6022367 Sherts Feb 2000 A
6024748 Manzo et al. Feb 2000 A
6030370 Kupka et al. Feb 2000 A
6030395 Nash et al. Feb 2000 A
6036699 Andreas et al. Mar 2000 A
6036700 Stefanchik et al. Mar 2000 A
6036702 Bachinski et al. Mar 2000 A
6036703 Evans et al. Mar 2000 A
6036704 Yoon Mar 2000 A
6036705 Nash et al. Mar 2000 A
6050472 Shibata Apr 2000 A
6053390 Green et al. Apr 2000 A
6056762 Nash et al. May 2000 A
6066144 Wolf et al. May 2000 A
6066148 Rygaard May 2000 A
6068637 Popov et al. May 2000 A
6074416 Berg et al. Jun 2000 A
6080167 Lyell Jun 2000 A
6080173 Williamson, IV et al. Jun 2000 A
6083234 Nicholas et al. Jul 2000 A
6110188 Narciso, Jr. Aug 2000 A
6113612 Swanson et al. Sep 2000 A
6117148 Ravo et al. Sep 2000 A
6120432 Sullivan et al. Sep 2000 A
6146393 Wakabayashi Nov 2000 A
6149681 Houser et al. Nov 2000 A
6152937 Peterson et al. Nov 2000 A
6152945 Bachinski et al. Nov 2000 A
6165185 Shennib et al. Dec 2000 A
6167889 Benetti Jan 2001 B1
6171319 Nobles et al. Jan 2001 B1
6171321 Gifford, III et al. Jan 2001 B1
6176413 Heck et al. Jan 2001 B1
6176864 Chapman Jan 2001 B1
6186942 Sullivan et al. Feb 2001 B1
6187019 Stefanchik et al. Feb 2001 B1
6187020 Zegdi et al. Feb 2001 B1
6190396 Whitin et al. Feb 2001 B1
6190397 Spence et al. Feb 2001 B1
6190590 Randall et al. Feb 2001 B1
6193129 Bittner et al. Feb 2001 B1
6193734 Bolduc et al. Feb 2001 B1
6206912 Goldsteen et al. Mar 2001 B1
6206913 Yencho et al. Mar 2001 B1
6235054 Berg et al. May 2001 B1
6371964 Vargas et al. Apr 2002 B1
6391036 Berg et al. May 2002 B1
6485496 Suyker et al. Nov 2002 B1
6494889 Fleischman et al. Dec 2002 B1
6508822 Peterson et al. Jan 2003 B1
6537288 Vargas et al. Mar 2003 B2
6652541 Vargas et al. Nov 2003 B1
6695859 Golden et al. Feb 2004 B1
6699256 Logan et al. Mar 2004 B1
6736825 Blatter et al. May 2004 B2
6776785 Yencho et al. Aug 2004 B1
6786914 Vargas et al. Sep 2004 B1
6790229 Berreklouw Sep 2004 B1
6790889 Hergenrother et al. Sep 2004 B2
20020082614 Logan et al. Jun 2002 A1
20020169466 Peterson et al. Nov 2002 A1
Foreign Referenced Citations (84)
Number Date Country
29713335 Nov 1997 DE
0 517 252 Dec 1992 EP
0 701 800 Mar 1996 EP
0 885 595 Dec 1998 EP
0 938 870 Sep 1999 EP
0 820 724 Jan 2000 EP
0 820 725 Jan 2000 EP
0 913 125 Jul 2000 EP
0 990 420 Dec 2000 EP
9208513 May 1992 WO
9625886 Aug 1996 WO
9725002 Jul 1997 WO
9727898 Aug 1997 WO
9731575 Sep 1997 WO
9747261 Dec 1997 WO
9807399 Feb 1998 WO
9819608 May 1998 WO
9819618 May 1998 WO
9819625 May 1998 WO
9819629 May 1998 WO
9819630 May 1998 WO
9819631 May 1998 WO
9819632 May 1998 WO
9819634 May 1998 WO
9819636 May 1998 WO
9830153 Jul 1998 WO
9837814 Sep 1998 WO
9842262 Oct 1998 WO
9847430 Oct 1998 WO
9855027 Dec 1998 WO
9908603 Feb 1999 WO
9917665 Apr 1999 WO
9918887 Apr 1999 WO
9921491 May 1999 WO
9937218 Jul 1999 WO
9938441 Aug 1999 WO
9938454 Aug 1999 WO
9940851 Aug 1999 WO
9940868 Aug 1999 WO
9945848 Sep 1999 WO
9952481 Oct 1999 WO
9962406 Dec 1999 WO
9962409 Dec 1999 WO
9962415 Dec 1999 WO
9963910 Dec 1999 WO
9965409 Dec 1999 WO
0009040 Feb 2000 WO
0108601 Feb 2000 WO
0010486 Mar 2000 WO
0012013 Mar 2000 WO
0015144 Mar 2000 WO
0015146 Mar 2000 WO
0015147 Mar 2000 WO
0015148 Mar 2000 WO
0015149 Mar 2000 WO
0027310 May 2000 WO
0027311 May 2000 WO
0027312 May 2000 WO
0027313 May 2000 WO
0033745 Jun 2000 WO
0041633 Jul 2000 WO
WO-0044311 Aug 2000 WO
0053104 Sep 2000 WO
0056223 Sep 2000 WO
0056226 Sep 2000 WO
0056227 Sep 2000 WO
0056228 Sep 2000 WO
0059380 Oct 2000 WO
0066007 Nov 2000 WO
0066009 Nov 2000 WO
0069343 Nov 2000 WO
0069346 Nov 2000 WO
0069349 Nov 2000 WO
0069364 Nov 2000 WO
0072764 Dec 2000 WO
0074579 Dec 2000 WO
0076405 Dec 2000 WO
0112074 Feb 2001 WO
0115607 Mar 2001 WO
0117440 Mar 2001 WO
0119257 Mar 2001 WO
0119259 Mar 2001 WO
0119284 Mar 2001 WO
0134037 May 2001 WO
Related Publications (1)
Number Date Country
20030212418 A1 Nov 2003 US